06:48 AM EDT, 09/24/2024 (MT Newswires) -- Eli Lilly ( LLY ) said Tuesday that its Alzheimer's therapy Kisunla has received approval from Japan's Ministry of Health, Labour and Welfare for treatment of adults with early symptomatic Alzheimer's disease.

Japan is Kisunla's second major market following US approval in July this year.

Price: 919.20, Change: +0.68, Percent Change: +0.07